RASolute 302 Phase 3 catalyst, cash runway, and valuation risks for daraxonrasib. Read more macro analysis here.

Grew 56% to $102.5 million for the year; Q4 adjusted operating income was $17.6 million. Adjusted Operating Margin -- ...

Like any kind of tool, artificial intelligence, or AI, has the potential for both creation and destruction, its aptitude for one tempered only by its tendency for the other.

In which direction is America heading, amid the strategic cacophony of Trump’s second term—counter-revolution in the Caribbean, onslaught on Iran, somersaults on China? Analysis of the political ...